Placeholder Banner

BIO Statement Regarding Nomination of Robert F. Kennedy Jr.

November 14, 2024

BIO President & CEO John F. Crowley released the following statement:

“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served by strong leadership that respects and advances science, nutrition and medicine and ensures that the United States and our allies continue to lead the world in biotechnology. Indeed, the rich tradition of ‘gold-standard scientific research’ and ‘evidence-based science’ have always been at the core of our life-saving work to prevent, control and cure disease—and to provide access to healthy food security for all. This is the mission of America’s biotechnology companies. I have every confidence that we will continue to thrive and deliver on this important mission ahead. The world cannot wait. We look forward to working closely with President-elect Trump, his incoming Administration, and members of Congress on both sides of the aisle to achieve these mutual goals.”

 

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

Discover More
Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic performance, its impacts, and its geographic…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…